Why Sientra Shares Are Trading Higher By 84%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Lisa Levin
Sientra shares surged 83.9% in pre-market trading after announcing FDA-clearance of its next-generation AlloX2 Pro Tissue Expander. Other pre-market gainers include Advanced Health Intelligence, ContraFect Corporation, and Sonoma Pharmaceuticals, while Elevation Oncology, Baosheng Media Group, and Planet Labs were among the losers.
June 09, 2023 | 11:22 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Sientra's stock price surged 83.9% in pre-market trading after announcing FDA-clearance of its next-generation AlloX2 Pro Tissue Expander.
Sientra's FDA-clearance of its next-generation AlloX2 Pro Tissue Expander is a significant milestone for the company, which is likely to boost investor confidence and drive the stock price higher in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100